25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Vg Life Sciences Inc
Buy, Hold or Sell?

Let's analyze Vg Life Sciences Inc together

I guess you are interested in Vg Life Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vg Life Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Vg Life Sciences Inc

I send you an email if I find something interesting about Vg Life Sciences Inc.

1. Quick Overview

1.1. Quick analysis of Vg Life Sciences Inc (30 sec.)










1.2. What can you expect buying and holding a share of Vg Life Sciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$0.00
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
0.0%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0 - $0.0001
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Vg Life Sciences Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$0.00 - $0.00
Total Value Per Share
$0.00 - $0.00

2.2. Growth of Vg Life Sciences Inc (5 min.)




Is Vg Life Sciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$3.2m-$3.2m0.000.0%

How much money is Vg Life Sciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$2.5m$2.1m-$4.6m-183.6%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Vg Life Sciences Inc (5 min.)




2.4. Comparing to competitors in the Real Estate - Development industry (5 min.)




  Industry Rankings (Real Estate - Development)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Vg Life Sciences Inc?

Welcome investor! Vg Life Sciences Inc's management wants to use your money to grow the business. In return you get a share of Vg Life Sciences Inc.

First you should know what it really means to hold a share of Vg Life Sciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Vg Life Sciences Inc is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vg Life Sciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vg Life Sciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vg Life Sciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-119.9%0.00-119.9%0.00100.3%0.00-32.0%0.00-75.6%
Usd Book Value Change Per Share0.000.0%0.000.0%0.0018.4%0.0011.5%0.009.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.0018.4%0.0011.5%0.009.3%
Usd Price Per Share0.00-0.00-0.00-0.00-0.01-
Price to Earnings Ratio-0.83--0.83-1.00--110.02--131.45-
Price-to-Total Gains Ratio5.42--37.04--7,885.80-
Price to Book Ratio-0.64--0.64--0.64--8.00--61.28-
Price-to-Total Gains Ratio5.42--37.04--7,885.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (10000000 shares)0.00114.91
Gains per Year (10000000 shares)0.00459.62
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
100-100460450
200-100919910
300-10013791370
400-10018381830
500-10022982290
600-10027582750
700-10032173210
800-10036773670
900-10041374130
1000-10045964590

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.05.00.016.7%1.015.05.04.8%
Book Value Change Per Share0.00.01.00.0%2.00.01.066.7%2.02.01.040.0%2.03.01.033.3%7.013.01.033.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.06.00.0%0.00.021.00.0%
Total Gains per Share0.00.01.00.0%2.00.01.066.7%2.02.01.040.0%2.03.01.033.3%7.013.01.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Vg Life Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0%0.000-100%0.000-100%0.000-100%
Book Value Per Share--0.0000.0000%0.0000%0.000+47%0.000+45%
Current Ratio----0%-0%-0%0.007-100%
Debt To Asset Ratio--3.4903.4900%3.4900%4.651-25%4.610-24%
Debt To Equity Ratio--1.4451.4450%-+100%0.289+400%0.241+500%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0000.0000%0.000-220%0.000-73%0.000-37%
Free Cash Flow Per Share--0.0000.0000%0.000+26%0.000+13%0.000+3104%
Free Cash Flow To Equity Per Share----0%-0%-0%0.0000%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.000--------
Intrinsic Value_10Y_min--0.000--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min--0.000--------
Intrinsic Value_3Y_max--0.000--------
Intrinsic Value_3Y_min--0.000--------
Intrinsic Value_5Y_max--0.000--------
Intrinsic Value_5Y_min--0.000--------
Market Cap2109549.9780%2109549.9782109549.9780%2109549.9780%50207289.467-96%287953571.942-99%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio-0.6400%-0.640-0.6400%-0.6400%-7.998+1149%-61.284+9469%
Pe Ratio-0.8340%-0.834-0.8340%0.997-184%-110.020+13096%-131.446+15666%
Price Per Share0.0000%0.0000.0000%0.0000%0.002-96%0.014-99%
Price To Free Cash Flow Ratio-103.6990%-103.699-103.6990%-82.530-20%-37.246-64%-159.930+54%
Quick Ratio----0%-0%-0%0.001-100%
Return On Assets---1.912-1.9120%1.599-220%-0.511-73%-1.553-19%
Return On Equity---0.792-0.7920%--100%-0.158-80%-0.132-83%
Total Gains Per Share----0%0.000-100%0.000-100%0.000-100%
Usd Book Value---3294023.000-3294023.0000%-3294023.0000%-4830658.000+47%-4776551.667+45%
Usd Book Value Change Per Share----0%0.000-100%0.000-100%0.000-100%
Usd Book Value Per Share--0.0000.0000%0.0000%0.000+47%0.000+45%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0000.0000%0.000-220%0.000-73%0.000-37%
Usd Free Cash Flow---20343.000-20343.0000%-25561.000+26%-9180.800-55%-325893.833+1502%
Usd Free Cash Flow Per Share--0.0000.0000%0.000+26%0.000+13%0.000+3104%
Usd Free Cash Flow To Equity Per Share----0%-0%-0%0.0000%
Usd Market Cap2109549.9780%2109549.9782109549.9780%2109549.9780%50207289.467-96%287953571.942-99%
Usd Price Per Share0.0000%0.0000.0000%0.0000%0.002-96%0.014-99%
Usd Profit---2530247.000-2530247.0000%2115108.000-220%-675813.400-73%-2054753.500-19%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share----0%0.000-100%0.000-100%0.000-100%
 EOD+0 -0MRQTTM+0 -0YOY+5 -105Y+8 -1610Y+8 -18

3.3 Fundamental Score

Let's check the fundamental score of Vg Life Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.834
Price to Book Ratio (EOD)Between0-1-0.640
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.000
Debt to Asset Ratio (MRQ)Less than13.490
Debt to Equity Ratio (MRQ)Less than11.445
Return on Equity (MRQ)Greater than0.15-0.792
Return on Assets (MRQ)Greater than0.05-1.912
Total0/10 (0.0%)

3.4 Technical Score

Let's check the technical score of Vg Life Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Vg Life Sciences Inc

VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide (CLIP) that is displayed on specific B cells that leads to chronic inflammation. The company also provides metabolic disruption technology (MDT) compounds impede tumor cells that sensitize cancer cells to treatment by disrupting the metabolic strategies those cells use to survive; and Hydroxychloroquine, a MDT compound that can be used in combination with other cancer drugs for treating drug-resistant cancers. In addition, it offers targeted peptide technology (TPT), a technology that eliminates the subpopulation of pro-inflammatory immune cells and presents a possible treatment for autoimmune and infectious diseases. VG Life Sciences Inc. was formerly known as Viral Genetics Inc. and changed its name to VG Life Sciences Inc. in November 2012. The company was founded in 1995 and is based in Santa Barbara, California. VG Life Sciences Inc. is a subsidiary of KH Feelux Co., Ltd.

Fundamental data was last updated by Penke on 2024-11-07 15:54:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Vg Life Sciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Vg Life Sciences Inc to the Real Estate - Development industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vg Life Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Real Estate - Development)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.9%-1.9%
TTM-12.2%-12.2%
YOY-12.1%-12.1%
5Y-13.8%-13.8%
10Y-14.3%-14.3%
4.3.1.2. Return on Assets

Shows how efficient Vg Life Sciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vg Life Sciences Inc to the Real Estate - Development industry mean.
  • -191.2% Return on Assets means that Vg Life Sciences Inc generated $-1.91 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vg Life Sciences Inc:

  • The MRQ is -191.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -191.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-191.2%TTM-191.2%0.0%
TTM-191.2%YOY159.9%-351.1%
TTM-191.2%5Y-51.1%-140.2%
5Y-51.1%10Y-155.3%+104.2%
Compared to industry (Real Estate - Development)
PeriodCompanyIndustry (mean)+/- 
MRQ-191.2%0.1%-191.3%
TTM-191.2%0.4%-191.6%
YOY159.9%0.8%+159.1%
5Y-51.1%1.4%-52.5%
10Y-155.3%1.5%-156.8%
4.3.1.3. Return on Equity

Shows how efficient Vg Life Sciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vg Life Sciences Inc to the Real Estate - Development industry mean.
  • -79.2% Return on Equity means Vg Life Sciences Inc generated $-0.79 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vg Life Sciences Inc:

  • The MRQ is -79.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -79.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-79.2%TTM-79.2%0.0%
TTM-79.2%YOY--79.2%
TTM-79.2%5Y-15.8%-63.3%
5Y-15.8%10Y-13.2%-2.6%
Compared to industry (Real Estate - Development)
PeriodCompanyIndustry (mean)+/- 
MRQ-79.2%0.2%-79.4%
TTM-79.2%1.4%-80.6%
YOY-2.9%-2.9%
5Y-15.8%4.6%-20.4%
10Y-13.2%4.4%-17.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Vg Life Sciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Vg Life Sciences Inc is operating .

  • Measures how much profit Vg Life Sciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vg Life Sciences Inc to the Real Estate - Development industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vg Life Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Real Estate - Development)
PeriodCompanyIndustry (mean)+/- 
TTM--13.8%+13.8%
YOY-17.6%-17.6%
5Y-11.9%-11.9%
10Y-13.8%-13.8%
4.3.2.2. Operating Ratio

Measures how efficient Vg Life Sciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Real Estate - Development industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vg Life Sciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Real Estate - Development)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.660-1.660
TTM-1.298-1.298
YOY-0.881-0.881
5Y-0.903-0.903
10Y-0.878-0.878
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Vg Life Sciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Vg Life Sciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Real Estate - Development industry mean).
  • A Current Ratio of 0.00 means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vg Life Sciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.007-0.007
Compared to industry (Real Estate - Development)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.449-1.449
TTM-1.623-1.623
YOY-1.923-1.923
5Y-1.950-1.950
10Y0.0072.007-2.000
4.4.3.2. Quick Ratio

Measures if Vg Life Sciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vg Life Sciences Inc to the Real Estate - Development industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vg Life Sciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.001-0.001
Compared to industry (Real Estate - Development)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.051-0.051
TTM-0.272-0.272
YOY-0.302-0.302
5Y-0.597-0.597
10Y0.0010.751-0.750
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Vg Life Sciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Vg Life Sciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vg Life Sciences Inc to Real Estate - Development industry mean.
  • A Debt to Asset Ratio of 3.49 means that Vg Life Sciences Inc assets are financed with 349.0% credit (debt) and the remaining percentage (100% - 349.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vg Life Sciences Inc:

  • The MRQ is 3.490. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 3.490. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ3.490TTM3.4900.000
TTM3.490YOY3.4900.000
TTM3.4905Y4.651-1.161
5Y4.65110Y4.610+0.041
Compared to industry (Real Estate - Development)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4900.729+2.761
TTM3.4900.722+2.768
YOY3.4900.713+2.777
5Y4.6510.705+3.946
10Y4.6100.661+3.949
4.5.4.2. Debt to Equity Ratio

Measures if Vg Life Sciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vg Life Sciences Inc to the Real Estate - Development industry mean.
  • A Debt to Equity ratio of 144.5% means that company has $1.44 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vg Life Sciences Inc:

  • The MRQ is 1.445. The company is able to pay all its debts with equity. +1
  • The TTM is 1.445. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.445TTM1.4450.000
TTM1.445YOY-+1.445
TTM1.4455Y0.289+1.156
5Y0.28910Y0.241+0.048
Compared to industry (Real Estate - Development)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4452.707-1.262
TTM1.4452.616-1.171
YOY-2.518-2.518
5Y0.2892.439-2.150
10Y0.2412.164-1.923
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Vg Life Sciences Inc generates.

  • Above 15 is considered overpriced but always compare Vg Life Sciences Inc to the Real Estate - Development industry mean.
  • A PE ratio of -0.83 means the investor is paying $-0.83 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vg Life Sciences Inc:

  • The EOD is -0.834. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.834. Based on the earnings, the company is expensive. -2
  • The TTM is -0.834. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.834MRQ-0.8340.000
MRQ-0.834TTM-0.8340.000
TTM-0.834YOY0.997-1.831
TTM-0.8345Y-110.020+109.186
5Y-110.02010Y-131.446+21.427
Compared to industry (Real Estate - Development)
PeriodCompanyIndustry (mean)+/- 
EOD-0.834164.852-165.686
MRQ-0.834131.813-132.647
TTM-0.834731.285-732.119
YOY0.9977.228-6.231
5Y-110.02045.584-155.604
10Y-131.44643.090-174.536
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vg Life Sciences Inc:

  • The EOD is -103.699. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -103.699. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -103.699. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-103.699MRQ-103.6990.000
MRQ-103.699TTM-103.6990.000
TTM-103.699YOY-82.530-21.169
TTM-103.6995Y-37.246-66.453
5Y-37.24610Y-159.930+122.684
Compared to industry (Real Estate - Development)
PeriodCompanyIndustry (mean)+/- 
EOD-103.699-15.917-87.782
MRQ-103.699-12.727-90.972
TTM-103.699-4.171-99.528
YOY-82.5301.053-83.583
5Y-37.2461.088-38.334
10Y-159.930-0.535-159.395
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Vg Life Sciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Real Estate - Development industry mean).
  • A PB ratio of -0.64 means the investor is paying $-0.64 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Vg Life Sciences Inc:

  • The EOD is -0.640. Based on the equity, the company is expensive. -2
  • The MRQ is -0.640. Based on the equity, the company is expensive. -2
  • The TTM is -0.640. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.640MRQ-0.6400.000
MRQ-0.640TTM-0.6400.000
TTM-0.640YOY-0.6400.000
TTM-0.6405Y-7.998+7.358
5Y-7.99810Y-61.284+53.286
Compared to industry (Real Estate - Development)
PeriodCompanyIndustry (mean)+/- 
EOD-0.6401.277-1.917
MRQ-0.6401.021-1.661
TTM-0.6401.122-1.762
YOY-0.6401.345-1.985
5Y-7.9981.672-9.670
10Y-61.2841.736-63.020
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
 As reported
Total Liabilities 0
Total Stockholder Equity+ 0
Total Assets = 0

Assets

Total Current Assets
Total Current Assets  (as reported)0
Total Current Assets  (calculated)0
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities
Total Current Liabilities  (as reported)0
Total Current Liabilities  (calculated)0
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)0
+/-0
Other
Common Stock Shares Outstanding 18,701,511



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
> Total Assets 
57
5
5,353
5,310
5,537
6,787
6,357
1,023
932
1,853
3,195
3,098
3,090
1,083
1,866
1,323
0
0
0
0
0
000001,3231,8661,0833,0903,0983,1951,8539321,0236,3576,7875,5375,3105,353557
   > Total Current Assets 
0
0
0
0
265
1,402
180
0
0
0
0
0
9
6
789
246
0
0
0
0
0
0000024678969000001801,4022650000
       Cash And Cash Equivalents 
44
2
0
0
5
1,402
180
0
0
0
16
7
6
6
714
34
0
0
0
0
0
0000034714667160001801,402500244
       Short-term Investments 
0
0
0
0
260
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000002600000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
97
9
3
0
75
212
0
0
0
0
0
0000021275039970000000000
   > Long-term Assets 
0
0
5,353
5,310
5,272
5,385
6,177
980
0
0
0
0
0
0
1,077
1,077
0
0
0
0
0
000001,0771,0770000009806,1775,3855,2725,3105,35300
       Property Plant Equipment 
0
0
147
104
64
136
961
980
889
19
0
0
0
0
0
0
0
0
0
0
0
00000000000198899809611366410414700
       Goodwill 
0
0
5,206
0
0
0
5,173
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000005,1730005,20600
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
100
0
0
0
0
0
0
0
0
00000000100000000000000
       Intangible Assets 
0
0
5,206
5,206
5,206
5,206
0
0
0
1,734
2,982
2,982
2,981
1,077
1,077
1,077
0
0
0
0
0
000001,0771,0771,0772,9812,9822,9821,7340005,2065,2065,2065,20600
       Other Assets 
0
3
0
0
2
43
44
1,023
43
0
0
0
0
0
0
0
0
0
0
0
0
000000000000431,023444320030
> Total Liabilities 
155
266
9,457
9,553
9,993
2,513
3,162
8,347
5,586
6,496
3,375
5,110
4,104
5,280
6,335
5,829
7,722
8,806
5,006
4,617
0
04,6175,0068,8067,7225,8296,3355,2804,1045,1103,3756,4965,5868,3473,1622,5139,9939,5539,457266155
   > Total Current Liabilities 
155
266
195
6,910
2,271
569
978
5,846
3,225
3,238
1,627
3,138
2,812
5,280
6,335
5,829
7,722
8,806
5,006
4,617
0
04,6175,0068,8067,7225,8296,3355,2802,8123,1381,6273,2383,2255,8469785692,2716,910195266155
       Short-term Debt 
0
0
1
5
270
0
0
43
0
0
0
0
411
3,567
3,208
3,861
3,873
4,655
2,609
2,181
0
02,1812,6094,6553,8733,8613,2083,567411000043002705100
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
411
3,567
3,208
3,861
0
0
0
0
0
000003,8613,2083,567411000000000000
       Accounts payable 
0
5
167
267
242
281
829
388
621
1,420
728
543
564
392
405
710
0
0
0
0
0
000007104053925645437281,42062138882928124226716750
       Other Current Liabilities 
0
20
26
6,638
1,759
288
149
5,415
1,063
1,668
629
1,010
0
706
2,217
723
3,849
4,152
2,397
2,436
0
02,4362,3974,1523,8497232,21770601,0106291,6681,0635,4151492881,7596,63826200
   > Long-term Liabilities 
0
0
9,263
2,643
7,722
1,944
2,184
2,501
0
0
0
0
0
0
3,613
4,572
0
0
0
0
0
000004,5723,6130000002,5012,1841,9447,7222,6439,26300
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000
> Total Stockholder Equity
0
-1,116
-4,105
-4,243
-4,456
4,274
3,195
-7,324
0
0
0
0
-1,056
-4,896
-5,167
-5,171
-8,214
-9,264
-5,464
-4,617
0
0-4,617-5,464-9,264-8,214-5,171-5,167-4,896-1,0560000-7,3243,1954,274-4,456-4,243-4,105-1,1160
   Retained Earnings 0-116,928-115,861-114,621-113,166-105,969-99,779-92,360-81,2820000-54,054-26,122-21,545-14,602-10,159-8,382-2,0660
   Accumulated Other Comprehensive Income 0-1,746-279-48-130000000000000000
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-20
Operating Income-20-20
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense200
 
Net Interest Income (+$)
Interest Income0
Interest Expense-68
Other Finance Cost-68
Net Interest Income0
 
Pretax Income (+$)
Operating Income-20
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,5302,490
EBIT - interestExpense = -257
-2,698
-2,462
Interest Expense68
Earnings Before Interest and Taxes (EBIT)-188-2,462
Earnings Before Interest and Taxes (EBITDA)-20
 
After tax Income (+$)
Income Before Tax-2,530
Tax Provision-0
Net Income From Continuing Ops0-2,530
Net Income-2,530
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses20
Total Other Income/Expenses Net-2,5100
 

Technical Analysis of Vg Life Sciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vg Life Sciences Inc. The general trend of Vg Life Sciences Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vg Life Sciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vg Life Sciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0 > 0 > 0.

Tweet this
Vg Life Sciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vg Life Sciences Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vg Life Sciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vg Life Sciences Inc. The current macd is 0.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vg Life Sciences Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Vg Life Sciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Vg Life Sciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Vg Life Sciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartVg Life Sciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vg Life Sciences Inc. The current adx is 100.00.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Vg Life Sciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Vg Life Sciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vg Life Sciences Inc. The current sar is 0.0001.

Vg Life Sciences Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vg Life Sciences Inc. The current rsi is 0. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Vg Life Sciences Inc Daily Relative Strength Index (RSI) ChartVg Life Sciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vg Life Sciences Inc. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vg Life Sciences Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Vg Life Sciences Inc Daily Stochastic Oscillator ChartVg Life Sciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vg Life Sciences Inc. The current cci is -95.23809524.

Vg Life Sciences Inc Daily Commodity Channel Index (CCI) ChartVg Life Sciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vg Life Sciences Inc. The current cmo is 0.

Vg Life Sciences Inc Daily Chande Momentum Oscillator (CMO) ChartVg Life Sciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vg Life Sciences Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Vg Life Sciences Inc Daily Williams %R ChartVg Life Sciences Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vg Life Sciences Inc.

Vg Life Sciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vg Life Sciences Inc. The current atr is 0.000039.

Vg Life Sciences Inc Daily Average True Range (ATR) ChartVg Life Sciences Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vg Life Sciences Inc. The current obv is -2,042,137,559.

Vg Life Sciences Inc Daily On-Balance Volume (OBV) ChartVg Life Sciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vg Life Sciences Inc. The current mfi is 6.94005814.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Vg Life Sciences Inc Daily Money Flow Index (MFI) ChartVg Life Sciences Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vg Life Sciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-31MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-02MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-03MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-07MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Vg Life Sciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vg Life Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Vg Life Sciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Vg Life Sciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vg Life Sciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vg Life Sciences Inc

I send you an email if I find something interesting about Vg Life Sciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Vg Life Sciences Inc.

Receive notifications about Vg Life Sciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.